Pancreatic cancer

28,366views

Pancreatic cancer

Endocrine Midterm

Endocrine Midterm

Pituitary gland histology
Pituitary apoplexy
Pituitary adenoma
Hypopituitarism: Pathology review
Anatomy of the diencephalon
Sheehan syndrome
Hypopituitarism
Kallmann syndrome
Hypoprolactinemia
Hyperprolactinemia
Pituitary tumors: Pathology review
Thyroid and parathyroid gland histology
Parathyroid disorders and calcium imbalance: Pathology review
Anatomy of the thyroid and parathyroid glands
DiGeorge syndrome
Parathyroid hormone
Hypoparathyroidism
Thymic aplasia
Hyperparathyroidism
Hyperparathyroidism: Clinical sciences
Approach to hypocalcemia: Clinical sciences
Hyperphosphatemia
Hypercalcemia
Bone remodeling and repair
Hypomagnesemia
Approach to hypocalcemia (pediatrics): Clinical sciences
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Thyroid nodules: Clinical sciences
Thyroid carcinoma: Clinical sciences
Thyroid hormones
Thyroid eye disease (NORD)
Thyroid storm
Hashimoto thyroiditis
Postpartum thyroiditis
Riedel thyroiditis
Hashimoto thyroiditis: Clinical sciences
Subacute granulomatous thyroiditis
Anatomy clinical correlates: Viscera of the neck
Approach to hypothyroidism: Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Hyperthyroidism: Pathology review
Euthyroid sick syndrome
Hypothyroidism: Pathology review
Hypothyroidism
Graves disease: Clinical Sciences
Hyperthyroidism medications
Hypothyroidism medications
Thyroglossal duct cyst
Pancreas histology
Pancreatic cancer
Pancreatitis: Pathology review
Chronic pancreatitis
Approach to pancreatic masses: Clinical sciences
Acute pancreatitis
Pancreatic secretion
Insulins
Insulin
Hypoglycemics: Insulin secretagogues
Pancreatic neuroendocrine neoplasms
Approach to hypoglycemia: Clinical sciences
Diabetes mellitus: Pathology review
Growth hormone deficiency
Diabetes mellitus
Hypokalemia
Diabetes mellitus (Type 1): Clinical sciences
Diabetic ketoacidosis: Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Approach to hyperkalemia: Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Approach to hypoglycemia (pediatrics): Clinical sciences
Hunger and satiety
Approach to diabetes in pregnancy: Clinical sciences
Glucagon
Growth hormone and somatostatin
Somatostatin
Managing diabetes during the holidays: Information for patients and families
Diabetes insipidus and SIADH: Pathology review
Diabetic nephropathy
Gestational diabetes
Chronic kidney disease: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Dyslipidemia: Clinical sciences
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Adrenal gland histology
Adrenal insufficiency: Pathology review
Congenital adrenal hyperplasia
Adrenal insufficiency: Clinical sciences
Adrenal masses: Pathology review
Primary adrenal insufficiency
Cushing syndrome
Pheochromocytoma: Clinical sciences
Glucocorticoids
Mineralocorticoids and mineralocorticoid antagonists
Cortisol
Cushing syndrome and Cushing disease: Clinical sciences
Endocrine system anatomy and physiology
Cushing syndrome and Cushing disease: Pathology review
Multiple endocrine neoplasia
Multiple endocrine neoplasia: Pathology review
Multiple endocrine neoplasia: Clinical sciences
Prolactinoma
Potassium sparing diuretics
Polycystic ovary syndrome (PCOS): Clinical sciences
Conn syndrome

Transcript

Watch video only

Content Reviewers

Pancreatic carcinoma describes the pancreas having cancerous cells arise.

Now a healthy pancreas has two types of glands, exocrine glands which sends digestive enzymes off to the small intestine, and endocrine glands which help regulate metabolism in the body, for example, maintaining normal blood sugar.

Over 95% of pancreatic tumors develop in the pancreas’s exocrine tissues, and of these, tumors arising in the epithelial cells lining the pancreatic ducts account for the vast majority of cases.

This type of pancreatic cancer is known as pancreatic adenocarcinoma due to the cells glandular-like (“adeno”) appearance under the microscope, often pancreatic adenocarcinoma is used interchangeably with pancreatic carcinoma.

These tumors typically form in the head or neck of the pancreas, but in some cases tumors form in the tail.

Around 5% of exocrine pancreatic carcinomas are caused by malignancies in the acinar cells, which are the cells that produce the digestive enzymes like trypsinogen, and around 1% are cystadenocarcinomas, or malignant cysts.

There are also other types of pancreatic cancer, but those are even more rare.

Generally, pancreatic carcinoma is caused by genetic mutations in the ductal epithelial cells, and these mutations might activate oncogenes which promote cancer or inactivate tumor suppressor genes.

Either way, this can lead to uncontrolled cell growth caused by the disruptions of the cell signalling pathways that regulate cell survival and growth, as well as multiple immune system responses like inflammation and stress responses.

Although it’s not exactly clear how the genetic mutations that trigger pancreatic carcinoma develop, there are some well known modifiable risk factors like smoking which increases the risk by two to five-fold, obesity, as well as eating a diet high in red meat.

There are also some non-modifiable risk factors like being male, being African American, and being over 65 years old.

Also, certain other diseases seem to increase the risk of developing pancreatic carcinoma as well, like diabetes, chronic pancreatitis, and liver cirrhosis, all of which are linked to excessive alcohol consumption, so there does seem to be an indirect relationship between pancreatic carcinoma and alcohol as well.

Finally, a family history of pancreatic cancer is also an important risk factor that increases individual risk, with inherited mutations in BRCA2, or breast cancer gene 2 being the most common cause of inherited pancreatic carcinoma, and mutations in PALB2 taking second place.

Initially symptoms are often vague, like nausea, vomiting, and fatigue.

There might also be weight loss, which may be due to cancer-associated anorexia, or malabsorption due to an obstructed pancreatic duct which can cause steatorrhea, foul-smelling greasy loose stools.

One of the most specific symptoms of pancreatic carcinoma is midepigastric pain that radiates to the mid- or lower-back, which often hurts the most at night when the individual is lying down flat.

Other classic symptoms that have been described include Trousseau sign, which is when blood clots, that can be felt as small lumps under the skin, appear unexpectedly in superficial veins, and then over time, migrate to different locations.

As well as Courvoisier sign, which is when the gallbladder is enlarged and palpable, and the patient does not find it at all tender to the touch, which is unlike gallstones. This occurs when the common bile duct is blocked by a tumor so this sign suggests the tumor is more likely in the head of the pancreas than the tail.

Key Takeaways

Pancreatic cancer is an aggressive tumor arising from the pancreatic duct mostly of the head or neck. The most common type of pancreatic cancer is pancreatic adenocarcinoma. Symptoms of pancreatic cancer can include abdominal pain radiating to the back, weight loss, jaundice, loss of appetite, nausea, and fatigue.

Pancreatic cancer is caused by genetic mutations in the ductal epithelial cells, which activate oncogenes that promote cancer or inactivate tumor suppressor genes. The risk factors include smoking, a family history of pancreatic cancer, and certain medical conditions such as diabetes and pancreatitis. Treatment for pancreatic cancer may include surgery, chemotherapy, or radiotherapy, depending on the stage of cancer and the patient's overall health.